Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3034 |
|
| Actual shortage: | 241 (8%) | |
| Anticipated shortage: | 18 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CEFUROXIME | 250MG | TABLET | Resolved | 2021-09-17 | 2021-10-12 | 145828 |
| APO-DESVENLAFAXINE | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-09-17 | 2021-10-12 | 145831 |
| APO-DONEPEZIL | 10MG | TABLET | Resolved | 2021-09-17 | 2021-09-27 | 145834 |
| APO-GABAPENTIN | 400MG | CAPSULE | Resolved | 2021-09-17 | 2021-11-22 | 145837 |
| APO-RIZATRIPTAN | 5MG | TABLET | Resolved | 2021-09-17 | 2021-11-08 | 145843 |
| APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2021-09-21 | 2021-10-25 | 145937 |
| APO-METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-09-21 | 2021-10-28 | 145949 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2021-09-24 | 2021-09-28 | 146151 |
| APO-DASATINIB | 70MG | TABLET | Resolved | 2021-09-24 | 2021-11-19 | 146154 |
| APO-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2021-09-24 | 2021-10-05 | 146157 |
| APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2021-09-24 | 2021-09-27 | 146160 |
| OVIMA 28 | 30MCG 150MCG | TABLET | Resolved | 2021-09-24 | 2021-11-15 | 146163 |
| APO-AMLODIPINE-ATORVASTATIN | 20MG 10MG | TABLET | Resolved | 2021-10-01 | 2021-11-15 | 146500 |
| APO-DARIFENACIN | 7.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-10-01 | 2022-01-24 | 146503 |
| APO-MEDROXY TABLETS | 5MG | TABLET | Resolved | 2021-10-01 | 2022-01-31 | 146508 |
| APO-NAPROXEN EC TABLETS | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2021-10-01 | 2021-10-01 | 146511 |
| APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2021-10-01 | 2021-12-06 | 146514 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2021-10-01 | 2021-10-20 | 146519 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2021-10-01 | 2021-10-25 | 146522 |
| APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-10-07 | 2021-12-06 | 146795 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
| APO-CILAZAPRIL | 1MG | TABLET | To be discontinued | 2018-09-07 | 2018-12-28 | 60373 |
| APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
| APO-DICLO RAPIDE 50 MG TABLETS | 50MG | TABLET | To be discontinued | 2018-09-07 | 2018-11-02 | 60423 |
| APO-METOPROLOL | 25MG | TABLET | To be discontinued | 2018-09-07 | 2021-06-03 | 60628 |
| APO-OXAZEPAM | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
| APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2018-09-08 | 2018-09-08 | 60753 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2019-01-03 | 2019-12-20 | 71026 |
| APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2019-01-04 | 2021-06-05 | 71354 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |
| APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-04-01 | 217493 |
| APO-CARVEDILOL | 3.125MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217496 |
| APO-CARVEDILOL | 6.25MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217499 |